58 related articles for article (PubMed ID: 30379559)
1. Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy.
Valle LF; Greer MD; Shih JH; Barrett T; Law YM; Rosenkrantz AB; Shebel H; Muthigi A; Su D; Merino MJ; Wood BJ; Pinto PA; Krauze AV; Kaushal A; Choyke PL; Türkbey B; Citrin DE
Diagn Interv Radiol; 2018; 24(1):46-53. PubMed ID: 29317377
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Prostate Cancer Recurrence with MR Imaging and Prostate Imaging for Recurrence Reporting Scoring System.
Pecoraro M; Dehghanpour A; Das JP; Woo S; Panebianco V
Radiol Clin North Am; 2024 Jan; 62(1):135-159. PubMed ID: 37973239
[TBL] [Abstract][Full Text] [Related]
3. The delineation of intraprostatic boost regions for radiotherapy using multimodality imaging.
Pathmanathan AU; Alexander EJ; Huddart RA; Tree AC
Future Oncol; 2016 Nov; 12(21):2495-2511. PubMed ID: 27322113
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Performance and Safety of
Mai Z; Zhou Z
J Urol; 2023 Sep; 210(3):410-411. PubMed ID: 37345476
[No Abstract] [Full Text] [Related]
5. Unlocking the Benefits of Multiparametric MRI for Predicting Prostate Cancer Recurrence.
Aguirre DA; Cardona Ortegón JD
Radiology; 2023 Nov; 309(2):e232819. PubMed ID: 37987663
[No Abstract] [Full Text] [Related]
6. Invited Commentary: Advanced Anatomic and Molecular Imaging in Recurrent Prostate Cancer.
Turkbey B
Radiographics; 2023 Dec; 43(12):e230215. PubMed ID: 37999985
[No Abstract] [Full Text] [Related]
7. Bullseye or Tip of the Iceberg: Magnetic Resonance Imaging-visible Disease in Radiorecurrent Prostate Cancer.
Kishan AU; Valle LF; Marks LS
Eur Urol; 2024 Jan; 85(1):47-48. PubMed ID: 37805372
[No Abstract] [Full Text] [Related]
8. A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome.
Ryg U; Seierstad T; Nilsen LB; Hellebust TP; Djupvik LH; Gustafson H; Hydal J; Kishan AU; Hole KH; Lilleby W
Front Oncol; 2022; 12():861127. PubMed ID: 35463376
[TBL] [Abstract][Full Text] [Related]
9. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
10. Imaging of Prostate Cancer Using Fluciclovine.
Savir-Baruch B; Zanoni L; Schuster DM
PET Clin; 2017 Apr; 12(2):145-157. PubMed ID: 28267449
[TBL] [Abstract][Full Text] [Related]
11. Localization of radio-recurrence within the prostate: anti-3-18F-FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard.
Tulipan AJ; Hole KH; Vlatkovic L; Revheim ME; Reijnen JS; Willoch F; Seierstad T; Lilleby W
Acta Radiol; 2019 Aug; 60(8):1028-1038. PubMed ID: 30379559
[No Abstract] [Full Text] [Related]
12. Prospective evaluation of fluciclovine (
Akin-Akintayo O; Tade F; Mittal P; Moreno C; Nieh PT; Rossi P; Patil D; Halkar R; Fei B; Master V; Jani AB; Kitajima H; Osunkoya AO; Ormenisan-Gherasim C; Goodman MM; Schuster DM
Eur J Radiol; 2018 May; 102():1-8. PubMed ID: 29685521
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of imaging techniques for detecting of local recurrence after prostate brachytherapy.
Karahissarlian V; Sargos P; Blais E; Cazeau AL; Fontes F; Petitpierre F; Rigou G; De Vaugelade C; Mariey A; Hindié E; Thomas L
Cancer Radiother; 2020 Jul; 24(4):323-331. PubMed ID: 32532578
[TBL] [Abstract][Full Text] [Related]
14. Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.
Odewole OA; Tade FI; Nieh PT; Savir-Baruch B; Jani AB; Master VA; Rossi PJ; Halkar RK; Osunkoya AO; Akin-Akintayo O; Zhang C; Chen Z; Goodman MM; Schuster DM
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1773-83. PubMed ID: 27091135
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Recurrence, Detection Rates, and Impact of 18-F Fluciclovine PET/CT on the Management of Men With Recurrent Prostate Cancer.
Michael J; Khandani AH; Basak R; Tan HJ; Royce TJ; Wallen E; Whang Y; Rose TL; Milowsky M; Bjurlin MA
Urology; 2021 Sep; 155():192-198. PubMed ID: 33516829
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
